Table 6.
Ten representative differentially-expressed genes upon LACCE treatment.
| Gene Expression | Accession Number | Gene Function | Gene Symbol | log2 (Fold Change) | p-Value |
|---|---|---|---|---|---|
| Down-regulated | NM_002167.4 | inhibitor of DNA binding 3, HLH protein | ID3 | −1.352225574 | 1.33E-07 |
| Down-regulated | NM_014391.2 | ankyrin repeat domain 1 | ANKRD1 | −3.246186082 | 2.88E-07 |
| Down-regulated | NM_014899.3 | Rho related BTB domain containing 3 | RHOBTB3 | −1.143226842 | 2.39E-06 |
| Down-regulated | NR_003286.4 | RNA, 18S ribosomal N5 | RNA18SN5 | −2.579638571 | 3.86E-211 |
| Up-regulated | NM_000067.2 | carbonic anhydrase 2 | CA2 | 1.410938268 | 1.2145E-06 |
| Up-regulated | NM_000598.4 | insulin like growth factor binding protein 3 | IGFBP3 | 1.073197686 | 5.02E-16 |
| Up-regulated | NM_002275.3 | keratin 15 | KRT15 | 1.785827844 | 1.96E-23 |
| Up-regulated | NM_004052.3 | BCL2 interacting protein 3 | BNIP3 | 1.614937875 | 6.09E-09 |
| Up-regulated | NM_005130.4 | fibroblast growth factor binding protein 1 | FGFBP1 | 1.668660016 | 2.60E-24 |
| Up-regulated | NM_019058.3 | DNA damage inducible transcript 4 | DDIT4 | 1.192362381 | 5.33E-09 |
The 10 differentially-expressed genes upon LACCE treatment were identified based on adjusted p-value less than 0.001 and log2 (fold change) more than 1.